{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:00Z","timestamp":1781636040912,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University","award":["YJ(ZD)202301"],"award-info":[{"award-number":["YJ(ZD)202301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer remains one of the most lethal malignancies worldwide, underscoring the urgent need for reliable biomarkers to predict prognosis and guide therapy. This study aimed to identify and characterize such biomarkers using an integrated bioinformatics and experimental approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The GEO database was used to screen genes differentially expressed in pancreatic cancer. Next, the DAVID database was used for GO functional enrichment and KEGG pathway analyses. STRING database and Cytoscape software were utilized to generate PPI networks and identify key genes. The prognostic value was then evaluated by utilizing the GEPIA database and Cox regression analysis. The relationship between key genes and clinicopathological parameters was analyzed using the UALCAN database. The TISCH2, TIMER, and TISDB databases were used for immune infiltration analysis. The functional role of the key gene was ultimately confirmed through in vitro experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Through multiple rounds of strict screening, 10 key genes were obtained. After further verification, it was determined that MMP1 was significantly upregulated in pancreatic cancer tissue and correlated with poor prognosis\u00a0in patients. Immunological analysis revealed correlations between MMP1 expression and the infiltration of specific immune cells (B cells, M1 macrophages, neutrophils, and monocytes) as well as the expression of immune checkpoint genes (VTCN1, LGALS9, TGFBR1, and IL10RB). In vitro\u00a0functional assays confirmed that MMP1 knockdown in pancreatic cancer cells\u00a0suppressed proliferation, migration, and invasion, while promoting apoptosis. Furthermore, a co-culture model demonstrated that MMP1 facilitated the recruitment of M1-polarized macrophages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MMP1 is an independent prognostic biomarker that drives pancreatic cancer progression through direct oncogenic effects and modulation of the tumor immune microenvironment. Thus, it emerges as an attractive, multifunctional therapeutic target, which calls for future research to confirm its translational potential and delineate the underlying molecular pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15685-0","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:34:49Z","timestamp":1770878089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MMP1 is a promising prognostic, therapeutic and immunological biomarker for pancreatic cancer: evidence from bioinformatics analysis and biological experiments"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaini","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"3","key":"15685_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"15685_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164(5):752\u201365.","journal-title":"Gastroenterology"},{"issue":"1","key":"15685_CR3","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"15685_CR4","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1097\/CM9.0000000000003640","volume":"138","author":"Z Wu","year":"2025","unstructured":"Wu Z, Wang W, Hua J, Zhang J, Liu J, Shi S, et al. SMUG1 promoted the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1. Chin Med J (Engl). 2025;138(20):2640\u201356.","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"15685_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2174\/0929866529666220726144619","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang J, Jia J, Qian B, Tian X. Circ_0008768 suppresses the pancreatic cancer progression via miR-330-3p\/PTEN axis. Protein Pept Lett. 2022;29(9):796\u2013805.","journal-title":"Protein Pept Lett"},{"key":"15685_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"15685_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78(6):1019\u201333.","journal-title":"Mol Cell"},{"issue":"4","key":"15685_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/0929866530666230213113835","volume":"30","author":"L Periyasamy","year":"2023","unstructured":"Periyasamy L, Murugantham B, Sundaraj R, Krishnamoorthi S, Muthusami S. Screening of MMP-2 inhibiting phytoconstituents for the development of newer pancreatic cancer treatment modalities. Protein Peptide Lett. 2023;30(4):304\u201313.","journal-title":"Protein Peptide Lett"},{"issue":"10","key":"15685_CR9","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.3390\/curroncol29100541","volume":"29","author":"R Mukherji","year":"2022","unstructured":"Mukherji R, Debnath D, Hartley ML, Noel MS. The role of immunotherapy in pancreatic cancer. Curr Oncol. 2022;29(10):6864\u201392.","journal-title":"Curr Oncol"},{"issue":"4","key":"15685_CR10","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10528-024-10844-z","volume":"63","author":"NN Tang","year":"2025","unstructured":"Tang NN, Xu RB, Jiang B, Zhang HL, Wang XS, Chen DD, et al. AHNAK2 regulates NF-\u03baB\/MMP-9 signaling to promote pancreatic cancer progression. Biochem Genet. 2025;63(4):2912\u201324.","journal-title":"Biochem Genet"},{"issue":"2","key":"15685_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1042\/BST20210640","volume":"50","author":"SR Van Doren","year":"2022","unstructured":"Van Doren SR. MMP-7 marks severe pancreatic cancer and alters tumor cell signaling by proteolytic release of ectodomains. Biochem Soc Trans. 2022;50(2):839\u201351.","journal-title":"Biochem Soc Trans"},{"issue":"Database issue","key":"15685_CR12","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 2013;41(Database issue):D991\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"15685_CR13","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15685_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"D1","key":"15685_CR15","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"15685_CR16","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"15685_CR17","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-102.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"15685_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"1","key":"15685_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"Web Server issu","key":"15685_CR20","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38(Web Server issue):W214\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"15685_CR21","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49(D1):D1420\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"15685_CR22","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15685_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01806-w","volume":"10","author":"F Guo","year":"2024","unstructured":"Guo F, Tao X, Wu Y, Dong D, Zhu Y, Shang D, et al. Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1. Cell Death Discov. 2024;10(1):58.","journal-title":"Cell Death Discov"},{"issue":"1","key":"15685_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12891","volume":"27","author":"X Hu","year":"2023","unstructured":"Hu X, Zhang R, Yao J, Mu B, Zhao C. Wild-type KRAS inhibits the migration and invasion of pancreatic cancer through the Wnt\/\u03b2-catenin pathway. Mol Med Rep. 2023;27(1):4.","journal-title":"Mol Med Rep"},{"issue":"1","key":"15685_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, et al. Decoding the impact of MMP1+ malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11(1):244.","journal-title":"Cell Death Discov"},{"issue":"1","key":"15685_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6(1):153.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"15685_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030491","volume":"13","author":"YFI Setargew","year":"2021","unstructured":"Setargew YFI, Wyllie K, Grant RD, Chitty JL, Cox TR. Targeting lysyl oxidase family meditated matrix cross-linking as an anti-stromal therapy in solid tumours. Cancers (Basel). 2021;13(3):491.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"15685_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15(1):34.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"15685_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11010-020-03944-y","volume":"476","author":"C Wang","year":"2021","unstructured":"Wang C, Mao C, Lai Y, Cai Z, Chen W. MMP1 3\u2019UTR facilitates the proliferation and migration of human oral squamous cell carcinoma by sponging miR-188-5p to up-regulate SOX4 and CDK4. Mol Cell Biochem. 2021;476(2):785\u201396.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"15685_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.7314\/APJCP.2014.15.3.1085","volume":"15","author":"L Yadav","year":"2014","unstructured":"Yadav L, Puri N, Rastogi V, Satpute P, Ahmad R, Kaur G. Matrix metalloproteinases and cancer - roles in threat and therapy. Asian Pac J Cancer Prev. 2014;15(3):1085\u201391.","journal-title":"Asian Pac J Cancer Prev"},{"key":"15685_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jss.2021.04.021","volume":"266","author":"A Jonsson","year":"2021","unstructured":"Jonsson A, Falk P, Angenete E, Hjalmarsson C, Ivarsson ML. Plasma MMP-1 expression as a prognostic factor in colon cancer. J Surg Res. 2021;266:254\u201360.","journal-title":"J Surg Res"},{"issue":"2","key":"15685_CR32","first-page":"1732","volume":"17","author":"QM Wang","year":"2019","unstructured":"Wang QM, Lv L, Tang Y, Zhang L, Wang LF. MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors in vitro. Oncol Lett. 2019;17(2):1732\u201340.","journal-title":"Oncol Lett"},{"issue":"2","key":"15685_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/dna.2019.5129","volume":"39","author":"S Zhao","year":"2020","unstructured":"Zhao S, Yu M. Identification of MMP1 as a potential prognostic biomarker and correlating with immune infiltrates in cervical squamous cell carcinoma. DNA Cell Biol. 2020;39(2):255\u201372.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"15685_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2478\/s11658-010-0043-z","volume":"16","author":"A Khanna","year":"2011","unstructured":"Khanna A, Mahalingam K, Chakrabarti D, Periyasamy G. Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells. Cell Mol Biol Lett. 2011;16(1):101\u201313.","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"15685_CR35","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.apsb.2021.11.001","volume":"12","author":"T Zhong","year":"2022","unstructured":"Zhong T, Zhang W, Guo H, Pan X, Chen X, He Q, et al. The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies. Acta Pharm Sin B. 2022;12(4):1761\u201380.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"15685_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041164","volume":"11","author":"Y Wei","year":"2023","unstructured":"Wei Y, Khalaf AT, Rui C, Abdul Kadir SY, Zainol J, Oglah Z. The emergence of TRP channels interactome as a potential therapeutic target in pancreatic ductal adenocarcinoma. Biomedicines. 2023;11(4):1164.","journal-title":"Biomedicines"},{"issue":"5","key":"15685_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051021","volume":"10","author":"G Mesquita","year":"2021","unstructured":"Mesquita G, Prevarskaya N, Schwab A, Lehen\u2019kyi V. Role of the TRP channels in pancreatic ductal adenocarcinoma development and progression. Cells. 2021;10(5):1021.","journal-title":"Cells"},{"issue":"4","key":"15685_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.neo.2017.01.004","volume":"19","author":"P Rybarczyk","year":"2017","unstructured":"Rybarczyk P, Vanlaeys A, Brassart B, Dhennin-Duthille I, Chatelain D, Sevestre H, et al. The transient receptor potential melastatin 7 channel regulates pancreatic cancer cell invasion through the Hsp90\u03b1\/uPA\/MMP2 pathway. Neoplasia. 2017;19(4):288\u2013300.","journal-title":"Neoplasia"},{"issue":"18","key":"15685_CR39","doi-asserted-by":"publisher","first-page":"16321","DOI":"10.18632\/oncotarget.3872","volume":"6","author":"WL Chen","year":"2015","unstructured":"Chen WL, Barszczyk A, Turlova E, Deurloo M, Liu B, Yang BB, et al. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion. Oncotarget. 2015;6(18):16321\u201340.","journal-title":"Oncotarget"},{"issue":"12","key":"15685_CR40","doi-asserted-by":"publisher","first-page":"1089550","DOI":"10.3389\/fonc.2022.1089550","volume":"13","author":"S Mao","year":"2023","unstructured":"Mao S, Xia A, Tao X, Ye D, Qu J, Sun M, et al. A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors. Front Oncol. 2023;13(12):1089550.","journal-title":"Front Oncol"},{"issue":"1","key":"15685_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00769-z","volume":"6","author":"M Zhang","year":"2021","unstructured":"Zhang M, Pan X, Fujiwara K, Jurcak N, Muth S, Zhou J, et al. Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism. Signal Transduct Target Ther. 2021;6(1):366.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"15685_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10620-020-06183-9","volume":"66","author":"J Wu","year":"2021","unstructured":"Wu J, Cai J. Dilemma and challenge of immunotherapy for pancreatic cancer. Dig Dis Sci. 2021;66(2):359\u201368.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"15685_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1259-z","volume":"38","author":"A Rotte","year":"2019","unstructured":"Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res. 2019;38(1):255.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"15685_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.20517\/cdr.2022.142","volume":"6","author":"L Akhuba","year":"2023","unstructured":"Akhuba L, Tigai Z, Shek D. Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma. Cancer Drug Resist. 2023;6(2):327\u201331.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"15685_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12530","volume":"276","author":"JR Podojil","year":"2017","unstructured":"Podojil JR, Miller SD. Potential targeting of B7-H4 for the treatment of cancer. Immunol Rev. 2017;276(1):40\u201351.","journal-title":"Immunol Rev"},{"issue":"1","key":"15685_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-023-00320-6","volume":"9","author":"G Av\u015far","year":"2023","unstructured":"Av\u015far G, Pir P. An integrated study to decipher immunosuppressive cellular communication in the PDAC environment. NPJ Syst Biol Appl. 2023;9(1):56.","journal-title":"NPJ Syst Biol Appl"},{"issue":"4","key":"15685_CR47","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1158\/1078-0432.CCR-09-1634","volume":"16","author":"Z Zhong","year":"2010","unstructured":"Zhong Z, Carroll KD, Policarpio D, Osborn C, Gregory M, Bassi R, et al. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells. Clin Cancer Res. 2010;16(4):1191\u2013205.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"15685_CR48","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6(6):e1792.","journal-title":"Cell Death Dis"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15685-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:08:02Z","timestamp":1781633282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15685-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15685"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15685-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not require ethical approval as it was based on analysis of public databases, commercially obtained tissue samples, and in vitro experiments using standard cell lines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}